KV Pharmaceutical Voluntarily Suspends All Shipments of its Approved Tablet-form Drugs
|
|
Date of Recall:
Tuesday, December 23rd, 2008
Recall Details:
ST. LOUIS – Dec. 23, 2008 – KV Pharmaceutical
has advised the U.S. Food and Drug Administration (FDA) that, effective midnight
Dec. 19, 2008, the company voluntarily suspended all shipments of all FDA approved
drug products in tablet form. KV Pharmaceutical is also recalling a single
production lot of Hydromorphone HCl 2 mg tablets (Lot 90219, Exp: 3/2010; NDC
58177-0620-04), a pain management drug, following the report of an oversized
tablet. Additional details on this recall were provided in an ETHEX Corporation
press release also issued today and will be posted on www.kvpharmaceutical.com.
At this time, the company is unable to determine when distribution of tablet-form
products will resume.
A full list of products included in the suspension of shipments can be viewed
on the Company’s website at www.kvpharmaceutical.com, where a link can be found
on the home page to “Products Effected by Shipment Suspension”.
There are currently no comments for this recall. Be the first to !
to add a comment about this recall.
